Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa.
about
Clinical and preclinical treatment of urologic diseases with phosphodiesterase isoenzymes 5 inhibitors: an updateNormal male sexual function: emphasis on orgasm and ejaculationMolecular pathophysiology of priapism: emerging targetsTime-lapse imaging as a tool to investigate contractility of the epididymal duct--effects of cGMP signalingThe pathophysiology of acquired premature ejaculationExpression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferensVasoactive intestinal polypeptide, an erectile neurotransmitter, improves erectile function more significantly in castrated rats than in normal ratsShort hairpin ribonucleic acid constructs targeting insulin-like growth factor binding protein-3 rehabilitated decreased testosterone concentrations in diabetic ratsEffects of testosterone on sexual function in men: results of a meta-analysis.Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction.The role of the urologist in the prevention and early detection of cardiovascular disease.Impact of androgen deprivation therapy on sexual functionOntogenetic profile of the expression of thyroid hormone receptors in rat and human corpora cavernosa of the penisTestosterone deficiency causes penile fibrosis and organic erectile dysfunction in aging men. Evaluating association among Age, TDS and EDTestosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?Testosterone regulates smooth muscle contractile pathways in the rat prostate: emphasis on PDE5 signaling.Partial androgen deficiency, depression, and testosterone supplementation in aging men.Androgen deficiency and hormone-replacement therapy.Synergetic effect of testosterone and phophodiesterase-5 inhibitors in hypogonadal men with erectile dysfunction: A systematic reviewPeripheral regulatory mechanisms in erection.Endocrine causes of erectile dysfunction.The therapeutic dilemma: how to use tadalafil.Upregulation of Phosphodiesterase type 5 in the Hyperplastic Prostate.Dramatic improvement of penile venous leakage upon testosterone administration. A case report and review of literature.The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease.Phosphodiesterase type 5 inhibitors: back and forward from cardiac indicationsThe triad of erectile dysfunction, hypogonadism and the metabolic syndrome.Treatment Strategy for Non-Responders to PDE5 Inhibitors.Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction.Testosterone treatment to mimic hormone physiology in androgen replacement therapy. A view on testosterone gel and other preparations available.Which patients with sexual dysfunction are suitable for testosterone replacement therapy?The relationship between hypogonadism and erectile dysfunction.Lack of direct androgen regulation of PDE5 expression.Markers of erectile dysfunction.The use of phosphodiesterase 5 inhibitors with concomitant medications.Phosphodiesterase-5 expression and function in the lower urinary tract: a critical review.Partial androgen deficiency, depression and testosterone treatment in aging men.Clinical implication of endothelial progenitor cells.Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review.Cardiovascular diseases and erectile dysfunction: the two faces of the coin of androgen deficiency.
P2860
Q26775925-E9B58930-84BE-48EA-A584-423C94992219Q26783193-5DB4AF4C-6176-4895-A085-FA8107DDE2BDQ27010069-783A5AF3-B8BC-43F6-ACFA-D7E4873FAC54Q27313846-D02568DC-4BFD-410E-8680-89BA1AE533AEQ28066668-71FDCD42-D206-48E6-8218-700DE1F4892DQ28212847-81C35144-B40C-4A40-A28C-882963E22F6AQ28574595-E0E5CC73-B7B1-4A9E-AF7F-ACC779EFDA0AQ28854279-782D1EE1-BD3B-48E6-9736-F1CFDB54C83AQ33223876-D17FCF89-2266-49E3-9180-9829D5A5AD0FQ33276072-2CBD1859-A668-4333-9418-D61ED4691498Q34108216-9B95FA2A-4F32-4D55-A966-9CF10E13E0BCQ34245932-32099C27-DE95-497A-8108-63F29DEF20FFQ34474852-A98A1E5B-69D3-49B4-82D3-88465D6DE7FDQ34485718-2A8CE72C-D93A-4BF1-AC62-ADFC9140929AQ35076387-71116B42-BB8F-4983-9902-747CFD4F6722Q35924409-CDB45D77-095F-4F47-A26B-5195EEE9866DQ36036536-1889AD2C-7667-4644-A487-AFD02EBCD434Q36185648-D55EF0B9-D566-40A8-85FE-683203D60977Q36207705-9EE67303-0F5A-407E-A517-E9C2412781C4Q36290972-5B8ADE5D-4072-491B-A0A7-386437190241Q36290977-DEBEF91D-29D7-4755-96E1-4CE7AFBF3608Q36291011-242EDF0E-19CA-424B-A8FE-3226FE4FB0E6Q36360868-F120C5EB-C9CE-4607-8864-063DDEA62D16Q36371587-9DD1417E-9AA9-48F7-AF3D-3F6AB9031048Q36399555-2480C365-016B-4DF9-AD06-F4CCAE1A2575Q36460566-7A12EDAE-2900-48A6-8835-68C574F256EDQ36575143-DE1BFF9D-A5FB-4A7C-9898-EE492841A8B2Q36805917-A882BDAF-CC76-4896-8708-9B9971EFCD78Q36861695-31895FCF-31AB-4465-A9A0-FA37C4533748Q36897412-94C14A2E-4AC9-420B-B5EA-2054A61FE87CQ37030456-C829E4C8-A695-4CC3-92AA-39709DC34973Q37096549-7BE86D8F-5149-486C-8508-9AE83F14E053Q37187077-A98F3C11-976B-4F19-8F57-825D1795D179Q37197791-F587E8A8-E7B8-4F27-84E5-A9E28FC6CBD3Q37321940-00CE8E7C-44A5-4C35-8459-C513C4349BC2Q37340520-E589B482-322A-4FF4-9C5C-5E95AB421879Q37395634-1004CFB0-F10B-447A-9E19-E072E858CE87Q37661456-62187A7F-3405-4292-9284-336640D70CE9Q37778223-FEEFA674-890E-4290-AB8C-697D95F2B87BQ37827183-C670EFE1-4D92-45FE-909F-9C217F2638D3
P2860
Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Androgens regulate phosphodies ...... activity in corpora cavernosa.
@en
Androgens regulate phosphodies ...... activity in corpora cavernosa.
@nl
type
label
Androgens regulate phosphodies ...... activity in corpora cavernosa.
@en
Androgens regulate phosphodies ...... activity in corpora cavernosa.
@nl
prefLabel
Androgens regulate phosphodies ...... activity in corpora cavernosa.
@en
Androgens regulate phosphodies ...... activity in corpora cavernosa.
@nl
P2093
P50
P356
P1433
P1476
Androgens regulate phosphodies ...... activity in corpora cavernosa.
@en
P2093
Alessandro Natali
Claudio Orlando
Fabrizio Ledda
Gabriella Barbara Vannelli
Gianni Forti
Linda Vignozzi
Mauro Giorgi
Mirca Marini
Rosa Mancina
Sandra Filippi
P304
P356
10.1210/EN.2003-1699
P407
P577
2004-02-05T00:00:00Z